Therapy of relapsed/ refractory multiple myeloma with a combination of Lenalidomide plus Dexamethasone: First interim analysis of the non-interventional study “Revlimid.” 2. Juni 2013 Knauf, W., Aldaoud, A., Groschek, M., Teichmann, B., Harde, J., Hasskarl, J., 2013. Onkologie 36 (suppl. 7)(P532), 155. doi:10.1159/000356365 Abstract Treatment of indolent NHL by office-based haematologists in Germany: R-bendmustine replaces R-CHOP as “Standard of Care.” Knauf, W., Abenhardt, W., Nusch, A., Grugel, R., Marschner, N., 2013. Hematol Oncol 31 (Suppl. I)(Abstract 467), 248. doi:10.1002/hon.2059 Abstract… Weiterlesen Response to 1st-line Treatment with BR or FCR in Patients with Chronic Lymphocytic Leukaemia: First Outcome Data from the German Prospective TLN Registry. Knauf, W.U., Abenhardt, W., Engel, E., Grugel, R., Harde, J., Marschner, N., 2013. Blood 122(21), 4181. Abstract… Weiterlesen